Browse > Home / Health / FDA Panel Supports Roche Rheumatoid Arthritis Drug

FDA Panel Supports Roche Rheumatoid Arthritis Drug

July 30, 2008

An FDA panel has come out and recommended that the FDA approve a new rheumatoid arthritis drug from Roche Holdings AG, Actemra..Boston (ChattahBox) - An FDA panel has come out and recommended that the FDA approve a new rheumatoid arthritis drug from Roche Holdings AG, Actemra.

The rheumatoid arthritis drug Actemra does not come without its fair share of issues, such as causing liver problems, infections, etc.

The FDA panel, made up of medical experts, has stated though that the benefits of the new drug far outweigh the risks.

Roche has been working to get it approved to treat rheumatoid arthritis, which causes chronic pain for patients, and joint issues.

Typically, the FDA follows the advice of their panels.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists

Written by admin · Filed Under Health 


Comments

Got something to say?